(Oconomowoc, Wis.) Theodore E. Weltzin, M.D., F.A.E.D., F.A.P.A., the medical director of Eating Disorder Services at Rogers Memorial Hospital, addresses the issue of males and eating disorders in a general session of the 2013 National Eating Disorders Association (NEDA) conference on October 12 in Washington, D.C. The NEDA conference brings industry professionals, researchers, educators, people in recovery and families together to connect and learn the latest news on eating disorders, research and treatment.
Dr. Weltzin and Tim Freson, M.S., a counselor in Health and Wellness Services at Washington State University, will co-present “Be a Man? Gender Role Conformity, Sociocultural Pressures and Challenges in Eating Disorder Detection, Treatment and Recovery Among Males.” The session will discuss the unique barriers males often experience to accessing help and explore cultural risk factors impacting men. In addition, potential opportunities for increased detection and intervention will be addressed.
“I welcome the chance to talk about this timely subject,” Dr. Weltzin said. “Males with eating disorders are poorly understood and may not seek the treatment they need as a result. Presentations at conferences like NEDA’s are a great opportunity to improve public awareness and increase access to care.”
Rogers is a silver sponsor of this year’s conference, entitled “Of Monumental Importance: Directing the National Spotlight on Prevention, Treatment, Research and Policy.”
Rogers’ Place in the Industry
Eating disorders like anorexia, bulimia and binge eating disorder, along with co-occurring anxiety disorders, are treated successfully at Rogers’ residential Eating Disorder Center. Specialized programs for women, men, teens and children are aimed at getting to the core issue of the disorder in each patient. Rogers was the first provider in the nation to offer exclusive eating disorders treatment for men and boys and is the only program in the country to offer a specialized residential eating disorders treatment program for adults with co-occurring anxiety disorders.